Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5375 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-122 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-165 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-452 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-164 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-192 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 |
filingDate |
2019-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2022-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2022513193-A |
titleOfInvention |
Treatment of gastrointestinal disorders and their symptoms |
abstract |
Disclosed herein are methods of reducing inflammation and chronic pain in the gastrointestinal tract of subjects suffering from inflammatory bowel disease (IBD). Particularly disclosed is the depurine depyrimidine site endonuclease 1 oxidative reduction factor 1 (APE1 /) that blocks the depurine depyrimidine site endonuclease 1 (APE1) and regulates transcription factors (TF) involved in inflammation. Ref-1) A method of administering the inhibitor APX3330 to alleviate inflammatory or chronic pain. [Selection diagram] FIG. 1A |
priorityDate |
2018-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |